CNSX:BUZZ VanEck Social Sentiment ETF (BUZZ) Stock Price, News & Analysis → They say it’s ‘unstoppable’ – How I made 43,509% (From Investing Daily) (Ad) Free BUZZ Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get VanEck Social Sentiment ETF alerts: Email Address Ad True Market InsidersThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 About VanEck Social Sentiment ETF Stock (CNSX:BUZZ)Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally-derived approved drugs. It also distributes medical cannabis to pharmacies in Germany and rest of the European Union; and owns and operates in the psychedelic smartshop market. In addition, the company engages in the adult use psychedelic retail business; and researching and reformulating established natural medicines. It has a research agreement with the University of Michigan to evaluate N, N-dimethyltryptamine's (DMT) potential role in normal, diseased, and altered states of consciousness, as well as an agreement with Southwest Research Institute for initiating non-clinical and clinical manufacturing of Cepharanthine. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. The company is based in Toronto, Canada.Read More Ad True Market InsidersThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 BUZZ Stock News HeadlinesMarch 12, 2024 | techcrunch.comAnti-AI sentiment gets big applause at SXSW 2024 as moviemaker dubs AI cheerleading as ‘terrifying bullsh**’February 22, 2024 | msn.comVanEck Fined By the SEC Amidst ETF Marketing Violation; Crypto Experts Recommend InQubeta (QUBE) Over Polkadot (DOT)April 27, 2024 | True Market Insiders (Ad)The “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…February 17, 2024 | finance.yahoo.comVanEck Fined $1.75M Over Dave Portnoy's ETF RoleFebruary 16, 2024 | ft.comVanEck fined for disclosure failures over ETF promoted by Dave PortnoyJanuary 21, 2024 | seekingalpha.comConsumer sentiment jumps more than expected to highest since July 2021December 27, 2023 | seekingalpha.comBUZZ Investing: Stock Markets Rally As Fed Signals End To Rate HikesDecember 11, 2023 | msn.comWhat’s the Investor Interest and Market Growth Potential for VanEck’s Spot Bitcoin ETF?April 27, 2024 | True Market Insiders (Ad)The “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…December 8, 2023 | msn.comConsumer sentiment jumps in early December for the first increase in five monthsNovember 23, 2023 | seekingalpha.comBUZZ Investing: U.S. Stocks Fluctuate Amid Fed Policy PredictionsAugust 28, 2023 | cnbc.comWatch now: ETF Edge on the buzz around passive mutual fund policiesMay 19, 2023 | msn.comWall Street On the Brink of Rally? Momentum ETFs to TapMarch 29, 2023 | marketwatch.comThis stock ETF keeps beating the S&P 500 by selecting for qualityFebruary 24, 2023 | seekingalpha.comBUZZ VanEck Vectors Social Sentiment ETFFebruary 19, 2023 | seekingalpha.comBUZZ Investing: 2022's Hard Hit Stocks Continue To Rebound In 2023December 28, 2022 | baystreet.caInvesting Based on Social Sentiment Hasn't Paid Off for the BUZZ ETFNovember 23, 2022 | seekingalpha.comBUZZ Investing: Equities Rally Amidst Encouraging Inflation DataAugust 25, 2022 | msn.comThe 3 Hot New Meme Stocks List for September 2022July 23, 2022 | seekingalpha.comBUZZ Investing: Meme Stocks See Relief Amid Continued Macro UncertaintyMay 16, 2022 | msn.com'Meme' and tech stocks are crashing, so how are investors hanging on?February 22, 2022 | finance.yahoo.comVanEck Vectors ETF Trust - VanEck Vectors Social Sentiment ETF (BUZZ)September 15, 2021 | fool.comVanEck Vectors ETF Trust - VanEck Vectors Social Sentiment ETF(BUZZ)August 19, 2021 | morningstar.comAMC stock rises toward 4th-straight gain, to buck the weakness in meme stocks and the broader marketSee More Headlines Receive BUZZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Social Sentiment ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCNSX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCNSX:BUZZ CUSIPN/A CIKN/A Webwww.pharmadrug.co Phone647 202 1824FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Daniel CohenChairman & CEOMr. Keith Li (Age 40)Chief Financial Officer Comp: $91kDr. Paul Van SlykeChief Scientific OfficerHarry ResinPres of Super SmartKey CompetitorsAbattis BioceuticalsCNSX:ATTAgraflora Organics InternationalCNSX:AGRAAmplify Alternative Harvest ETFCNSX:MJBio-Rad LaboratoriesCNSX:BIOBlueberries MedicalCNSX:BBMView All Competitors BUZZ Stock Analysis - Frequently Asked Questions What other stocks do shareholders of VanEck Social Sentiment ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Social Sentiment ETF investors own include Aphria (APHA), Annovis Bio (ANVS), Amex Exploration (AMX), Amyris (AMRS), Aleafia Health (ALEAF), Aldeyra Therapeutics (ALDX), Agraflora Organics International (AGRA) and Acreage (ACRGF). How do I buy shares of VanEck Social Sentiment ETF? Shares of BUZZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (CNSX:BUZZ) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe World's First "$20 Trillion Drug?"Behind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Social Sentiment ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.